BTC $78,823.62 -1.11%
ETH $2,470.63 -0.41%
BNB $736.47 -1.13%
XRP $1.38 -1.94%
SOL $103.30 -2.37%
TRX $0.3338 -0.37%
DOGE $0.0890 +0.29%
ADA $0.2175 +0.09%
BCH $258.64 +1.32%
LINK $12.91 +5.67%
HYPE $85.23 -3.71%
AAVE $130.99 -1.88%
SUI $0.8057 +1.96%
XLM $0.1888 +2.71%
ZEC $1,157.58 -0.58%
BTC $78,823.62 -1.11%
ETH $2,470.63 -0.41%
BNB $736.47 -1.13%
XRP $1.38 -1.94%
SOL $103.30 -2.37%
TRX $0.3338 -0.37%
DOGE $0.0890 +0.29%
ADA $0.2175 +0.09%
BCH $258.64 +1.32%
LINK $12.91 +5.67%
HYPE $85.23 -3.71%
AAVE $130.99 -1.88%
SUI $0.8057 +1.96%
XLM $0.1888 +2.71%
ZEC $1,157.58 -0.58%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.